Your browser doesn't support javascript.
loading
Patient-Reported Outcomes in the Phase III BRIGHTE Trial of the HIV-1 Attachment Inhibitor Prodrug Fostemsavir in Heavily Treatment-Experienced Individuals.
Anderson, Sarah-Jane; Murray, Miranda; Cella, David; Grossberg, Robert; Hagins, Debbie; Towner, William; Wang, Marcia; Clark, Andrew; Pierce, Amy; Llamoso, Cyril; Ackerman, Peter; Lataillade, Max.
Afiliação
  • Anderson SJ; GlaxoSmithKline, Brentford, UK. sarah-jane.x.anderson@gsk.com.
  • Murray M; ViiV Healthcare, 980 Great West Road, Brentford, Middlesex, TW8 9GS, UK. sarah-jane.x.anderson@gsk.com.
  • Cella D; ViiV Healthcare, 980 Great West Road, Brentford, Middlesex, TW8 9GS, UK.
  • Grossberg R; Northwestern University Feinberg School of Medicine, Chicago, IL, USA.
  • Hagins D; Montefiore Medical Center, Bronx, NY, USA.
  • Towner W; Georgia Department of Public Health, Coastal Health District, Chatham CARE Center, Savannah, GA, USA.
  • Wang M; Southern California Kaiser Permanente Medical Group, Los Angeles, CA, USA.
  • Clark A; GlaxoSmithKline, Upper Providence, PA, USA.
  • Pierce A; ViiV Healthcare, 980 Great West Road, Brentford, Middlesex, TW8 9GS, UK.
  • Llamoso C; ViiV Healthcare, Research Triangle Park, NC, USA.
  • Ackerman P; ViiV Healthcare, Branford, CT, USA.
  • Lataillade M; ViiV Healthcare, Branford, CT, USA.
Patient ; 15(1): 131-143, 2022 01.
Article em En | MEDLINE | ID: mdl-34180035
Assuntos
Texto completo
Imprimir
XML
PubMed Links
Buscar no Google

Texto completo: 1 Base de dados: MEDLINE Assunto principal: Pró-Fármacos / Infecções por HIV / HIV-1 Tipo de estudo: Clinical_trials Limite: Humans Idioma: En Ano de publicação: 2022 Tipo de documento: Article
Texto completo
Imprimir
XML
PubMed Links
Buscar no Google

Texto completo: 1 Base de dados: MEDLINE Assunto principal: Pró-Fármacos / Infecções por HIV / HIV-1 Tipo de estudo: Clinical_trials Limite: Humans Idioma: En Ano de publicação: 2022 Tipo de documento: Article